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Although the function of the autonomic nervous system (ANS) in mediating the flight-or-fight response was
recognized decades ago, the crucial role of peripheral innervation in regulating cell behavior and response to
the microenvironment has only recently emerged. In the hematopoietic system, the ANS regulates stem cell
niche homeostasis and regeneration and fine-tunes the inflammatory response. Additionally, emerging data
suggest that cancer cells take advantage of innervating neural circuitry to promote their progression. These
new discoveries outline the need to redesign therapeutic strategies to target this underappreciated stromal
constituent. Here, we review the importance of neural signaling in hematopoietic homeostasis, inflammation,
and cancer.Introduction
The crosstalk between the CNS and periphery to maintain basal
and stress-related body homeostasis is largely exerted by the
hypothalamic-pituitary-adrenal (HPA) axis and the autonomic
nervous system (ANS). The ANS is comprised of two branches,
the sympathetic division emerging from the thoraco-lumbal spi-
nal cord, and the parasympathetic division derived from cranial
nerves and the sacral spinal cord (Figure 1). Functionally, the
sympathetic nervous system (SNS) prepares the body for alert
situations by activating the cardiovascular organs and increasing
blood flow to skeletal muscles and lungs, while suppressing
gastrointestinal activity. In contrast, the parasympathetic ner-
vous system (PNS) is more active in periods of rest and de-
creases muscle contractility and heart rate, while increasing
gastrointestinal function.
In recent years, the ANS emerged as an essential microenvi-
ronmental component of a variety of vertebrate tissues, regu-
lating homeostasis and influencing various pathologies. In the
liver, sympathetic and parasympathetic innervations regulate
both apoptosis and regeneration following partial hepatectomy
(Kiba, 2002). Autonomic innervation of the endocrine pancreas
also controls proliferation of pancreatic b cells in response to in-
sulin resistance, modulating pancreatic islet mass under patho-
logical conditions (Kiba, 2004; Imai et al., 2008). Brown adipose
tissue regulates thermogenesis and energy expenditure via
CNS-regulated sympathetic nerve activity (Morrison et al.,
2014). Additionally, peripheral nerves regulate the function of
multiple secretory organs. For example, innervation of the pros-
tate by both sympathetic and parasympathetic nerves regulates
epithelial cell growth and secretion by exerting contraction on
smooth muscle cells (Luja´n et al., 1998; Ventura et al., 2002).
Like most, if not all vascularized tissues, the sympathetic
branch of the ANS highly innervates the bone marrow, affecting360 Neuron 86, April 22, 2015 ª2015 Elsevier Inc.both hematopoiesis and bone formation. Initial studies revealed
thatbone formation viaosteoblast functionwas regulatedbycen-
tral leptin-mediated signals that activated the SNS and acted on
b2 adrenergic receptors on osteoblasts (Takeda et al., 2002).
Further studies showed that the mobilization of hematopoietic
stem cells (HSCs) into peripheral blood depended on adrenergic
modulation of the HSC microenvironment (Katayama et al.,
2006). Here, sympathetic signals traveling through adrenergic
nerve fibers of the bonemarrow locally release neurotransmitters
that activate adrenergic receptors expressed on niche cells.
Moreover, further studies have revealed that leukocyte trafficking
is influenced by a central molecular clock that coordinates circa-
dian secretion of noradrenaline from nerve terminals. Conveyed
through the hypothalamic-pituitary adrenal axis or the vagus
and adrenergic nerves, these signals induce release of neuro-
transmitters in the adrenal medulla or the spleen (Me´ndez-Ferrer
et al., 2008; Scheiermann et al., 2012). The ANS thus serves as
a major modulator of immune responses by exerting both pro-
and anti-inflammatory functions through influence on immune
effector cells. In this perspective, we review the neural regulation
of hematopoietic stem and immune cell behavior and discuss its
emerging role and implications in malignant pathology.
Neural Regulation of Hematopoiesis
Hematopoietic homeostasis is maintained through coordinated
proliferation, self-renewal, and differentiation of HSCs in the
bone marrow, leading to the development of the entire blood
system. HSCs are the only cell type capable of producing all
blood cell lineages throughout life, and their behavior is tightly
regulated by the local microenvironment, also termed the niche
(Morrison and Scadden, 2014). Regulatory elements within this
specialized niche are derived from surrounding stromal cells
and innervating sympathetic nerve fibers that coordinate HSC
Figure 1. Autonomic Neural Circuits
The autonomous nervous system (ANS) is comprised of a sympathetic division
(right) emerging from the thoraco-lumbal spinal cord, and a parasympathetic
division (left) derived from cranial nerves and the sacral spinal cord. The ANS
requires preganglionic and postganglionic neurons, forming synapses in the
autonomic ganglion to connect the CNS to its targets. (I) Sympathetic nerve
fibers in the bone marrow locally release neurotransmitters that activate
adrenergic receptors expressed on niche cells and thus regulate the mainte-
nance and retention of hematopoietic stem and progenitor cells in the bone
marrow. (II) Neural circuits composed of cholinergic and adrenergic neurons,
splenic T cells, and splenic macrophages regulate the innate immune
response. Activation of the HPA axis may also counter-balance inflammation
through glucocorticoids released from the adrenal cortex.
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Perspectivequiescence, a prerequisite for stem cell maintenance (Frenette
et al., 2013). To maintain homeostasis, HSCs are kept in a
dormant/quiescent state within the niche; however, in response
to stress, such as infection or radiation, they become activated in
order to replenish damaged blood cells and restore homeostasis
(Wilson et al., 2009). Because HSCs are highly dependent on
their microenvironment for normal function, damaging effects
to the bone marrow, such as radiation injury or high-dose
chemotherapy, contribute to diminish their function and impair
their regenerative capacity (Lucas et al., 2013; Cao et al.,
2011). The SNS represents a critical regulatory component of
the bone marrow niche, in which sympathetic nerve fibers and
neural crest-derived cells serve as major niche constituents,
essential for maintaining HSC behavior in both homeostasis
and stress (Katayama et al., 2006, Me´ndez-Ferrer et al., 2008,
Yamazaki et al., 2011).Neural Activity in the Bone Marrow Niche
The bone marrow microenvironment is formed by a complex
network of blood vessels, sympathetic nerve fibers, and stromal
cellular components integrating membrane-bound and locally
secreted signals that coordinate quiescence, proliferation, and
retention of HSCs and progenitor cells. The HSC niche was
initially identified as an osteoblastic unit (Zhang et al., 2003; Calvi
et al., 2003), where bone lining osteoblasts and osteolineage
cells were suggested to maintain HSC activity trough secretion
of angiopoietin-1 (Arai et al., 2004) and osteopontin (Opn) (Nils-
son et al., 2005; Stier et al., 2005). However, recent development
in imaging technology revealed that HSCs are primarily located
in proximity to perivascular stromal cells in the bone marrow
(Entschladen et al., 2004; Me´ndez-Ferrer et al., 2010b, Kunisaki
et al., 2013). In addition, conditional deletion of key HSCmainte-
nance factors, the CXCL12 chemokine and stem cell factor
(SCF), in osteolineage cells indicated that these cells had a negli-
gible effect on HSCmaintenance (Ding andMorrison, 2013; Ding
et al., 2012). The bone marrow vasculature is composed of two
types of blood vessels—sinusoids that are evenly distributed
throughout the marrow cavity and arterioles that are primarily
located near the endosteal bone region and highly innervated
by sympathetic nerves (Kunisaki et al., 2013). Several candidate
perivascular stromal cells have been suggested to regulate
healthy HSCs, including CXCL12-abundant reticular cells (Su-
giyama et al., 2006), Nestin-expressing cells (Me´ndez-Ferrer
et al., 2010b), and Leptin receptor (LepR)-expressing cells
(Ding et al., 2012) that exhibit significant overlap among each
other (Pinho et al., 2013). During development, neural crest-
derived cells migrate to the bone marrow and reside along the
blood vessels of the inner bone surface, where until adulthood,
they retain neural crest-associated gene expression including
nestin (Nagoshi et al., 2008; Takashima et al., 2007). Nestin-
expressing perivascular cells contain all bone marrow mesen-
chymal stem and progenitor cell (MSPC) activity and are highly
enriched for HSC maintenance and retention factors (Vcam1,
Cxcl12, Angpt1, Scf, and Opn) (Me´ndez-Ferrer et al., 2010b;
Pinho et al., 2013). In a transgenic reporter mouse, differential
nestin expression identifies distinct MSPC subset populations
in the perivascular niche. MSPC-expressing high nestin levels
associate with HSCs within arterioles and are characterized by
the expression of the NG2 pericyte marker. In contrast, lower
nestin expression identifies a more abundant reticular MSPC
population located around bone marrow sinusoids and enriched
for LepR expression (Kunisaki et al., 2013). These stromal LepR+
cells exhibit an MSPC phenotype and contribute to adipocyte
and bone regeneration (Mizoguchi et al., 2014, Zhou et al.,
2014). Interestingly, the rare arteriolar NG2+ pericytes are found
to be intimately associated with sympathetic nerve fibers and
GFAP+ Schwann cells and may harbor significantly higher
MSPC and HSC maintaining activity (Kunisaki et al., 2013).
Sympathetic nerve fibers in the bone marrow are spatially
closely associated with perivascular MSPCs around arteriolar
blood vessels, forming a structural network termed the neuro-
reticular complex (Kunisaki et al., 2013; Yamazaki and Allen,
1990; Me´ndez-Ferrer et al., 2010b) (Figure 2). Peripheral adren-
ergic signals released to the bone marrow negatively regulate
the mesenchymal fate and the proliferative state of nestin+Neuron 86, April 22, 2015 ª2015 Elsevier Inc. 361
Figure 2. Autonomic Signals Modulate Steady-State Hematopoiesis
Different stromal cell types, including nestin-expressing perivascular cells,
endothelial cells, and CAR cells, regulate HSC maintenance. Although
osteoblasts are dispensable for HSC maintenance, osteolineage cells may
contribute to HSC regulation and to lymphoid progenitor cells maintenance.
The neuronal components of the HSC niche comprise peripheral sympathetic
neurons and non-myelinating Schwann cells that maintain HSC dormancy
through activation of the TGF-b/SMAD signaling. Circadian noradrenaline
secretion from sympathetic nerves leads to circadian expression of CXCL12
by nestin+ MSPCs, resulting in rhythmic release of HSCs to the periphery. The
adrenergic signals in this case are mediated through the b3-adrenergic re-
ceptors (Adrb3). Quiescent HSCs are located in proximity to arteriolar blood
vessels, ensheathed with sympathetic nerve fibers and Nestinhigh NG2+ peri-
cytes; however, upon activation, relocate near the Nestinlow LepR-expressing
perisinusoidal area. Similar to MSPCs, sympathetic signals also regulate bone
formation via b2-adrenergic receptor (Adrb2) signaling in osteoblasts.
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leads to proliferation and expansion of normally quiescent
MSPCs while adrenergic stimulation, mediated through the
adrenergic b3-receptor, leads to decreased osteoblastic differ-
entiation and expression of HSC-regulating genes (Lucas et al.,
2013; Me´ndez-Ferrer et al., 2010b). Bone forming osteolineage
cells are also highly regulated by sympathetic nerve signals
(Katayama et al., 2006). The first indication that the SNS might
regulate bone turnover came from studies of leptin, a small poly-
peptide hormone, secreted by adipocytes. Leptin was identified
to control body weight and gonadal function by binding to
specific receptors located within the hypothalamus (Friedman
and Halaas, 1998). Surprisingly, leptin was also demonstrated
to act as a potent anti-osteogenic factor, indicated by increased
bone mass in leptin-deficient (ob/ob) and LepR-deficient (db/db)
mice (Ducy et al., 2000). Further studies found that sympathetic
signaling via b2-adrenergic receptors present on osteoblasts
controls bone formation downstream of leptin signaling (Takeda
et al., 2002). Thus, similar to MSPCs, sympathetic stimulation
negatively regulates the function of osteoblasts and presumably
also the more abundant osteocyte population in the compact
bone (Asada et al., 2013; Elefteriou et al., 2005). However, in
contrast to perivascular MSPCs that regulate the maintenance362 Neuron 86, April 22, 2015 ª2015 Elsevier Inc.and retention of HSCs, osteolineage cells appear to create a
niche for early lymphoid progenitors (Ding and Morrison, 2013;
Zhu et al., 2007). Still, the influence of osteoblast-mediated sym-
pathetic signaling on lymphoid progenitor development remains
to be fully characterized. Blood vessels lining endothelial cells
play an important role in promoting HSCs maintenance by
secreting SCF (Ding et al., 2012). In addition, stress-induced he-
matopoietic recovery following myeloablation seems to require
endothelial cells for proper regeneration and replenishment of
the HSPC population (Kobayashi et al., 2010). To date, the neural
regulation of endothelial cells in the bone marrow niche has not
been systematically addressed. However, endothelial cell and
MSPC numbers appear to recover in parallel during bone
marrow regeneration or after sympathetic denervation (Lucas
et al., 2013), suggesting a similar neural regulation for both of
these niche constituents.
Apart from sympathetic nerve fibers, other neural crest deriv-
atives have been shown to regulate HSC homeostasis. Nonmye-
linating Schwann cells that ensheathe nerve fibers of the bone
marrow were suggested to preserve HSC quiescence through
activation of transforming growth factor beta b (TGF-b) and
SMAD signaling (Yamazaki et al., 2011). Autonomic nerve
denervation resulted in a significant decrease in bone marrow
Schwann cells that was accompanied by a drastic increase in
HSC proliferation. However, it remains unclear how sympathetic
nerves can signal to Schwann cells and to what extent bone
marrow denervation, independent from Schwann cells and
TGF-b/SMAD signaling, contributed to the effects observed
on HSCs.
In addition to neural crest derivatives, neurotrophic factors
and neuropeptides, released by innervating nerve fibers and sur-
rounding cells, have been suggested to participate in formation
of hematopoietic environment in the bone marrow (Liu et al.,
2007). For instance, substance P and neurokinin-A, a tachykinin
family neuropeptides, have been suggested to stimulate produc-
tion of hematopoietic cytokines by bone marrow stromal cells
as well as serving as essential modulators of both normal and
malignant hematopoiesis (Nowicki et al., 2007).
Autonomic Regulation of Hematopoietic Homeostasis
Preliminary evidence that sympathetic signals might regulate
hematopoietic cells emerged several years ago when circadian
oscillations of noradrenaline content in murine bone marrow
was suggested to positively correlate with proliferation of bone
marrow hematopoietic cells (Maestroni et al., 1998). Initial impli-
cations of the SNS in maintaining HSPC homeostasis were
triggered by the discovery that a selectin glycomimetic inhibitor,
fucoidan, significantly mobilized HSPCs independent of selectin
itself (Frenette and Weiss, 2000; Sweeney et al., 2000). This
raised the possibility, that sulfated glycans in the bone marrow
microenvironment modulate HSPC motility. Galactocerebroside
(GalC) and its sulfated derivative, sulfatide, are the major
component of myelin sheaths responsible for adequate nerve
conduction (Norton and Cammer, 1984). Mice deficient for the
UDP-galactose ceramide galactosyltransferase (Cgt/ mice)
displayed no egress of HSPC from the bone marrow to the pe-
riphery upon enforced mobilization with granulocyte colony-
stimulating factor (G-CSF) (Katayama et al., 2006). Interestingly,
Cgt/mice also exhibited defects in lymphopoiesis associated
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tures (Katayama and Frenette, 2003). The defect in HSPC mobi-
lization inCgt/micewas not due to the lack of GalC production
but rather impaired adrenergic regulation of niche cells involved
in the mobilization of HSPCs (Katayama et al., 2006). Mobiliza-
tion of HSPCs is regulated by a gradient of the chemokine
CXCL12, whose levels in the bone marrow are downregulated
following G-CSF administration, leading to HSPC migration out
to the periphery (Hattori et al., 2001; Petit et al., 2002). Sympa-
thetic denervation in genetic and pharmacological models
prevented the CXCL12 downregulation after G-CSF treatment,
resulting in impaired HSPC mobilization (Katayama et al., 2006).
The aforementioned circadian oscillations of adrenergic activ-
ity in murine bone marrow are associated with circadian oscilla-
tion of CXCL12 expression and consequently rhythmic release of
HSPCs (Me´ndez-Ferrer et al., 2008). This postulates a model
where core genes of the molecular clock in the CNS act through
circadian noradrenaline secretion delivered by local sympathetic
nerve fibers. Sympathetic signals are then mediated through
adrenergic receptors expressed on bone marrow stromal cells
and lead to downregulation of CXCL12 expression. CXCL12 is
mostly secreted by perivascular MSPCs and to less extent by
osteolineage cells (Ding and Morrison, 2013; Greenbaum et al.,
2013). The adrenergic-stimulated release of HSPCs is mediated
by b3-adrenergic receptors that are almost exclusively ex-
pressed within the nestin-positive perivascular MSPC popula-
tion in the bone marrow stroma (Me´ndez-Ferrer et al., 2010b).
However, the enforced mobilization of HSPCs depends on
adrenergic signals mediated through both b2 and b3-adrenergic
receptors (Me´ndez-Ferrer et al., 2010a). Moreover, it is not only
the downregulation of CXCL12 in nestin+ MSPCs, but also the
suppression of macrophage function that contribute to G-CSF-
mediated HSC mobilization (Semerad et al., 2005; Chow et al.,
2011). This is also associated with suppression of osteolineage
cell function (Asada et al., 2013; Katayama et al., 2006; Semerad
et al., 2005, Christopher and Link, 2008). In addition, G-CSF-
induced mobilization leads to formation of larger gap spaces
between bone marrow endothelial cells (Szumilas et al., 2005),
accompanied by downregulation of the connexin-43 and 45
gap-junction proteins and lower CXCL12 expression in the niche
(Dar et al., 2006; Gonzalez-Nieto et al., 2012). At steady state,
connexin-43 and 45 were shown to influence the secretion of
functional CXCL12, whereas their inhibition resulted in impaired
homing of leukocytes to the bone marrow (Schajnovitz et al.,
2011). Efferent sympathetic nerve terminals and stromal cells
are inter-connected by gap junctions in adjacent sinusoids in
the bone marrow (Yamazaki and Allen, 1990). Therefore, it
cannot be excluded that sympathetic signals are propagated
through intercellular communication between niche cells thus
regulating HSPC homeostasis.
Similar to rodents, mobilized human HSPC counts fluctuate in
a circadian manner, although the circadian rhythm in humans is
inverted with significant higher yields of HSPCs toward the eve-
ning (Lucas et al., 2008). This finding may have clinical relevance
for the transplantation of HSPCs in benign and malignant dis-
ease (Gratwohl et al., 2013). Interestingly, human hematopoietic
progenitors can also be directly regulated by the sympathetic
signals, because immature human CD34+ progenitors expressdopamine receptors, which can be induced following G-CSF
mobilization (Spiegel et al., 2007). Catecholamine neurotrans-
mitters supported both motility and proliferation of human
CD34+ progenitors, suggesting that catecholamines can exert
both HSC-autonomous and non-autonomous (niche-mediated)
effects.
Autonomic Regulation of Hematopoietic Regeneration
The success of any hematopoietic stem cell transplantation
depends on harvesting a sufficient number of mobilized HSPCs
from the peripheral blood. In a subset of donors, the yield of
mobilized HSPCs is insufficient. In many cases, it appears to
be due to prior myelotoxic anti-cancer therapies that correlate
with poor mobilization (Perseghin et al., 2009; Robinson et al.,
2000). In murine type 1 and 2 diabetes mellitus models, enforced
mobilization of HSPCs to the blood is impaired, and this obser-
vation was confirmed in a small cohort of patients with diabetes
mellitus (Ferraro et al., 2011). These changes were mainly
referred to alterations within the bone marrow niche with a
reduction of osteoblasts and a surprising increase in nerve fibers
in calvarial bone marrow. Moreover, sensitization of b-adren-
ergic receptors was altered by the presence of diabetes mellitus.
In line with these findings, an impaired circadian release of endo-
thelial progenitor cells was observed in a rat type 2 diabetes mel-
litusmodel (Busik et al., 2009), but in contrast to the above study,
the authors reported sympathetic denervation of the bone
marrow. More recently, impaired mobilization of HSPCs and he-
matopoietic regeneration was linked to sympathetic neuropathy
of the bone marrow (Lucas et al., 2013). Sympathetic denerva-
tion—either pharmacologically induced or through specific
genetic deletion of sympathetic neurons—led to impaired he-
matopoietic regeneration after challenging denervated mice
with irradiation or myeloablation. The proposed model suggests
that sympathetic neuropathy damages the bone marrow niche
by driving nestin+MSPCs and endothelial cells into the cell cycle,
making them more vulnerable to genotoxic insults. After expo-
sure to cytotoxic agents, the niche size decreases and fails to
support hematopoietic regeneration (Figure 3). Administration
of the neuroprotective agents 4-methylcatechol (4-MC), or the
glial-derived neurotrophic factor (GDNF) concomitantly with
the neurotoxic drugs rescued sympathetic nerve fibers (Lucas
et al., 2013). This combined treatment saved bone marrow niche
cells from genotoxic insults and allowed normal hematopoietic
regeneration and efficient enforced mobilization of HSPCs
despite prior neurotoxic treatment. These data clearly indicate
that diseases or therapies that are accompanied by peripheral
neuropathy might have an as yet unappreciated long-term
damaging effect on hematopoiesis that may be preventable.
Neural Regulation of Inflammation
During an innate immune response, sensory nerves are activated
by inflammatory signals, leading to the release of neurotransmit-
ters and neuropeptides (Deutschman and Tracey, 2014). Neuro-
peptides, including corticotropin-releasing hormone, substance
P, and calcitonin gene-related peptide, trigger the release of pro-
inflammatory mediators (Pavlov and Tracey, 2012; Chiu et al.,
2013; von Hehn et al., 2012) that promote the inflammatory
response through increased vasodilatation, blood flow, vascular
leakiness, and pain. The resulting activation of the HPA axis viaNeuron 86, April 22, 2015 ª2015 Elsevier Inc. 363
Figure 3. Sympathetic Denervation Compromises Hematopoietic
Regeneration
Sympathetic neuropathy of the bone marrow damages the HSCs niche by
driving proliferation of nestin+ MSPCs and endothelial cells. SNS injury to the
bone marrow disrupts HSC and progenitor mobilization, and with damaging
events such as chemotherapy or radiation, the niche size decreases and fails
to support hematopoiesis.
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counter-balance inflammation through glucocorticoids released
from the adrenal cortex (Sternberg, 2006).
The SNS provides signals in the initial phase of inflammation.
Some studies suggest that noradrenaline mediates stimulation
of the immune response by influencing immune cell migration
(Sternberg, 2006), indicating that regional proinflammatory sig-
nals may serve to sustain local innate immune response. At the
same time, in vitro experiments have shown an immunosuppres-
sive effect of noradrenaline on monocytes and dendritic cells by
suppression of pro-inflammatory cytokines and enhanced pro-
duction of anti-inflammatory cytokines (Maestroni and Mazzola,
2003; van der Poll et al., 1994). This complexity becomes
obvious in denervation experiments in murine models of arthritis
where in the early phase of disease the SNS shows proinflamma-
tory effects, but at later stages, adrenergic signals have an
anti-inflammatory impact (Ha¨rle et al., 2005). Noradrenaline
has proinflammatory effects at low concentrations, mediated
through a-adrenergic receptors, and predominantly anti-inflam-
matory effects at high concentrations, mediated through
b-adrenergic receptors depending on the time point of activation
relative to inflammation (Pongratz and Straub, 2013). The
expression pattern of both a- and b-adrenergic receptors on
innate immune cells depends on the cell type and its activation
state. For example, T and B lymphocytes exclusively express
the b2-adrenergic receptors, whereas murine TH2 cells lack
expression of adrenergic receptors (Padro and Sanders, 2014).
Furthermore, the expression levels of adrenergic receptors as
well as the receptor binding capacity on immune cells are adap-
tive to environmental requirements. For example, peripheral364 Neuron 86, April 22, 2015 ª2015 Elsevier Inc.blood mononuclear cells have been suggested to express lower
levels of b2-adrenergic receptors in patients with rheumatoid
arthritis compared with healthy subjects (Baerwald et al.,
1992). In active juvenile rheumatoid arthritis, leukocytes have a
lower cAMP response to b2-adrenergic agonist indicating defec-
tive neuroimmune response (Kuis et al., 1996), whereas func-
tional a1-adrenergic receptors are upregulated (Heijnen et al.,
1996). Together with altered adrenergic receptor expression pat-
terns during chronic inflammation, the local innervation pattern
of sensory and sympathetic nerve fibers is altered with a shift
toward proinflammatory sensory nerves (Miller et al., 2000; Rey-
nolds and Fitzgerald, 1995).
A localized immune response depends on a regulated recruit-
ment of leukocytes to the inflammatory site. Adrenergic signals
have been suggested to regulate leukocyte trafficking to sites
of inflammation (Viswanathan and Dhabhar, 2005). This action
is mediated at least in part by an influence of the SNS on adhe-
sion molecule expression on venular endothelial cells (Scheier-
mann et al., 2012). Adrenergic activity is delivered locally by
nerve terminals and is controlled by themolecular clock resulting
in a circadian oscillation in adhesion molecule expression and
leukocyte recruitment with the peak recruitment occurring at
night, the period of activity in rodents. At times of higher SNS
tone, mice exhibited an increased sensitivity to inflammatory
stimuli. In contrast, cholinergic stimulation has been reported
to suppress the expression of endothelial cell adhesion mole-
cules via the nicotinic acetylcholine receptor alpha7 subunit
(a7nAChR), (Saeed et al., 2005), suggesting the potential for
opposing action of the SNS and the PNS in the inflammatory
response.
The PNS senses the inflammatory reaction through IL-1b re-
ceptors expressed on vagus nerve afferents and chemosensory
cells in paraganglia surrounding afferent vagus nerve endings
(Goehler et al., 2000). This appears to represent an initial step
in the inflammatory reflex of early inflammation where the PNS
counteracts the systemic inflammatory response through the
release of acetylcholine. The increased release of acetylcholine
inhibits endotoxin-induced release of pro-inflammatory but
not anti-inflammatory cytokines from macrophages through
a7nAChR (Borovikova et al., 2000; Wang et al., 2003). Anti-
inflammatory activity is supported by acetylcholine-mediated in-
hibition of the protein high-mobility group box 1 (HMGB1) (Wang
et al., 2004). HMBG1 is secreted by activated immune cells and
activates prototypical inflammatory responses in immune cells
and endothelial cells (Lotze and Tracey, 2005). Electrical stimu-
lation of the peripheral vagus nerve attenuates serum TNFa
levels and prevented development of shock during lethal
endotoxemia (Borovikova et al., 2000). Interestingly the anti-
inflammatory effect of vagus nerve stimulation also requires a
functional b2-adrenergic receptor on CD4+CD25 lymphocytes
(Vida et al., 2011). In contrast to SNS that innervates primary
and secondary lymphoid organs (Bellinger et al., 2008), there is
no definite evidence for efferent vagal or parasympathetic inner-
vation of the immune system (Figure 1) (Nance and Sanders,
2007; Scha¨fer et al., 1998). Indeed, vagus nerve stimulation ap-
pears to use sympathetic nerve relay to induce acetylcholine
production by memory CD4+ T cells in the spleen (Rosas-Ballina
et al., 2011). Thus, the neural circuits regulating immune
Neuron
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branches of the ANS. Interestingly, another recent study has
demonstrated that activation of the sensory sciatic nerve by
electro-acupuncture attenuated inflammation in an experimental
sepsis model via dopamine production in the adrenal glands
(Torres-Rosas et al., 2014), suggesting a new anti-inflammatory
mechanism mediated by the sciatic and vagus nerves modu-
lating the production of catecholamines.
The increasing understanding of neural circuit modulation of
immune responses and SNS-regulated mechanisms in leuko-
cyte trafficking open new therapeutic options to manage inflam-
mation-mediated diseases. Electrical stimulation and pharma-
cological approaches have already shown encouraging results.
Considering circadian fluctuations, time-dependent application
of therapies might finally boost anti-inflammatory effects.
Neural Regulation of Cancer
Consistent with complex neural influence, behavioral factors
including stress, depression and social isolation have been sug-
gested to contribute to pathogenesis (Chrousos and Gold,
1992). Epidemiological studies have attempted to identify corre-
lations between chronic stress and clinical outcome in cancer
patients. For example, womenwho suffered traumatic life events
had a 2-fold higher risk of developing breast cancer (Lillberg
et al., 2003). Moreover, chronic depression has been linked to
poor survival and highermortality in a large variety of tumor types
(Chida et al., 2008). More recently, the follow up of a large cohort
of patients with localized prostate cancer showed reduced sur-
vival in patients who were also diagnosed with depression (Pra-
sad et al., 2014). Similarly, chronic stress induced by obesity and
diabetes has been shown to correlate with increased risk of can-
cer and poor survival among cancer patients with pre-existing
diabetes (Calle and Kaaks, 2004). Taking into account the role
of autonomic nerves in hematopoiesis and tissue morphogen-
esis, it is reasonable to think that neural-mediated stress signals
may affect tumor cell growth and vice versa. In this section, we
will focus on recent developments with regards to hematologic
and solid malignancies.
Leukemia
The deterioration of bone marrow microenvironment is sug-
gested to be an important step in the development of myeloid
leukemia (Walkley et al., 2007a, 2007b; Raaijmakers et al.,
2010, Zhang et al., 2012). Both chronic myeloproliferative neo-
plasms (MPNs) and acute myeloid leukemia (AML), have been
demonstrated to remodel their microenvironment to form
a self-reinforcing oncogenic unit at the expense of normal hema-
topoiesis. MPN and AML are stem cell-driven diseases where
leukemic stem cells (LSCs) arising from mutated HSCs or
committed progenitors preserve their capability to self-renew
and can contribute to relapse of the disease after therapy (Ishi-
kawa et al., 2007; Krause and Van Etten, 2007). Bone marrow
MSPCs and osteolineage cells play a central role in remodeling
the bone marrow niche to accommodate LSC expansion.
Leukemic myeloid cells target MSPCs by secreting specific che-
mokines and growth factors that differentiate them into function-
ally altered osteolineage precursors (Schepers et al., 2013).
Once expanded, they accumulate within the endosteal niche
as inflammatory myelofibrotic cells, severely compromised intheir ability to maintain normal HSC activity. However, a BCR-
ABL blast-crisis model was reported to lead to severe reduction
of both mature osteoblasts and osteoprogenitors (Frisch et al.,
2012). Activation of the osteoblast function in the BCR-ABL
model led to a significantly attenuated course of disease, and
by contrast, in MLL-AF9 AML, osteoblast specific activation of
parathyroid hormone (PTH) signaling led to an acceleration of
disease (Krause et al., 2013). Further, recent studies with the
MLL-AF9 model revealed that AML development expanded os-
teolineage-primed MSPCs at the expense of HSC-maintaining
NG2+ periarteriolar cells. The documented loss of MSPC
quiescence was accompanied by bone marrow sympathetic
neuropathy (Hanoun et al., 2014). Notably, the expanded osteo-
lineage-committed cells were blocked in their ability to differen-
tiate into mature osteoblasts, contributing to significant bone
loss. Adrenergic signals reinforcing AML were mediated through
the b2-adrenergic receptors expressed on stromal leukemic
niche cells. In line with a more differentiated niche with reduced
b3-adrenergic signaling, maintenance and retention of healthy
HSCs was significantly impaired. Sympathetic neuropathy
of the bone marrow was also found to be essential for
JAK2(V617F)-driven MPN (Arranz et al., 2014). Development of
chronic MPN in this model was accompanied with drastic reduc-
tion in bone marrow sympathetic nerve fibers, and ensheathing
Schwann cells. However, in contrast sympathetic neuropathy
was accompanied by reduced nestin+ MSPCs numbers through
increased apoptosis, possibly triggered by IL-1b production
by LSCs. This appears to contrast with the described MSPC
expansion and enforced differentiation contributing to the com-
mon myelofibrotic tissue formation in BCR-ABL-driven MPN
(Schepers et al., 2013). The adrenergic signal in this case was
propagated through the b3-adrenergic receptor, as the admin-
istration of b3-adrenergic agonist rescued nestin+ MSPC
numbers, blocked myelofibrosis and MPN development. Thus,
the blockade of adrenergic signaling has overall disease-pro-
moting effects in both MPN and AML, but it appears to differen-
tially alter the healthy HSC niche to the benefit of a putative LSC
(Figure 4). Clarification is required about the distinct niche re-
quirements for different subsets of leukemia. However, protec-
tion of the sympathetic innervation of the bone marrow may
represent a common niche-targeted approach to preserve
healthy HSCs while contributing to the emerging anti-leukemic
arsenal.
Solid Tumors
In his anatomy book, the French anatomist Cruveilhier describes
a process by which cancer cells invade the space surrounding
the nerves, called perineural invasion (Cruveilheir, 1835), now
known to be common in several cancer types (Liebig et al.,
2009). Perineural space is thought to provide cancer cells a
pro-survival and anti-apoptotic environment that allows extrac-
apsular spread of the growing tumor (Ayala et al., 2006; Bock-
man et al., 1994). Furthermore, certain cancer types take
advantage of neurotransmitters released by nerve fibers to boost
their growth and metastatic capacity (Entschladen et al., 2004).
Cancer cells can also attract nerves surrounding the tumor by
expression and secretion of axon guidance molecules and nerve
attractants (Ayala et al., 2008). This process implies an increase
in the number and extensions of axons, in contrast toNeuron 86, April 22, 2015 ª2015 Elsevier Inc. 365
Figure 4. Sympathetic Neuropathy Promotes Hematopoietic Malignancy
(A) AML induces sympathetic neuropathy of the leukemic niche. Development of MLL-AF9-driven AML disrupts SNS nerves within the leukemic bone marrow
niche. The SNS neuropathy is accompanied by expansion of nestin+ MSPCs primed for osteoblastic differentiation at the expense of HSC-maintaining Nestinhigh
NG2+ pericytes. In addition, AML is also associated with increased vascular density. The adrenergic signals regulating LSCs are transduced by the b2-adrenergic
receptor (Adrb2) expressed on stromal cells in leukemic bone marrow.
(B) Bone marrow neuropathy is essential for the development of MPN. Sympathetic nerve fibers, non-myelinating Schwann cells, and Nestin+ MSPCs are
consistently reduced in MPN bone marrow driven by JAK2(V617F) mutations in HSCs. In contrast to AML, the reduction in Nestin+ MSPCs is not due to
differentiation, but neural damage coinciding with Schwann cell and Nestin+ MSPCs apoptosis triggered by IL-1b production by mutant HSCs. Treatment with a
b3-adrenergic agonist blockedMPNprogression, suggesting that the adrenergic signals were transduced via the b3-adrenergic receptor (Adrb3) present onMPN
bone marrow stromal cells.
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Perspectiveneurogenesis, which is associated with an increase in neuronal
cell bodies. Such recruitment of nerves into the tumor has
been described in prostate, colon, bladder, and esophageal can-
cers (Liebig et al., 2009; Ayala et al., 2008; Palm and Entschla-
den, 2007; Magnon et al., 2013; Palm and Entschladen, 2007).
It is intriguing that the development of new nerves resembles
the development of new vascularization (angiogenesis) (Magnon
et al., 2013), raising important implications for future combina-
tion therapies.
Themechanisms of axonogenesis and the identity of neurotro-
phic factors secreted by the tumors to initiate their own innerva-
tion are not well understood. Some tumor types and cancer cell
lines are more neurotrophic than others by secreting neural
growth factor (NGF), brain-derived neurotrophic factor (BDNF)
and glial-derived neurotrophic factor (GDNF) to induce the
regeneration of neo-fibers in the tumors (Geldof et al., 1997; Ko-
walski and Paulino, 2002; Okada et al., 1999). In prostate cancer,
patients exhibit increased prostate nerve density (Ayala et al.,
2008; Magnon et al., 2013), and in vitro studies have revealed
that the attraction of PC-3 prostate cancer cells to neural cells
from dorsal root ganglion (DRG) was driven by semaphorin 4F,
a well characterized axon guidance molecule (de Wit and Ver-
haagen, 2003). More recently, the recruitment of both sympa-
thetic and parasympathetic fibers within the tumor has been
shown in vivo in human prostate cancer orthotopic xenografts
(Magnon et al., 2013). Data from a cohort of prostate cancer pa-366 Neuron 86, April 22, 2015 ª2015 Elsevier Inc.tients showed a significant correlation between patients with
high risk of prostate cancer and increased sympathetic fiber
(tyrosine hydroxylase-positive) densities in healthy tissue and
parasympathetic fiber (vesicular acetylcholine transporter-posi-
tive) densities inmalignant areas. In addition, analyses of primary
pancreatic tumors have revealed an enhanced neural density of
the pancreas (Ceyhan et al., 2009). Similar to prostate and
pancreatic cancers, increased sprouting of both sensory and
sympathetic nerve fibers was observed in the tumor-bearing re-
gions and the periosteum of a bone lesion model, in which
breast, prostate or sarcoma cancer cells were intrafemorally in-
jected (Bloom et al., 2011; Halvorson et al., 2005; Jimenez-
Andrade et al., 2011; Mantyh et al., 2010).
In several tumor types, autonomic nerves promote tumor
growth andmetastasis by acting on both cancer cells and the tu-
mor microenvironment (Chida et al., 2008). Adrenergic signals
can directly influence cancer development via stimulation of
b-adrenergic receptors expressed by tumor cells. For instance,
in breast and ovarian cancers, catecholaminergic signals are
predominantly mediated via the b2-adrenergic receptor,
expressed on the cancer cells, and can directly modulate their
invasive potential (Penninx et al., 1998; Sood et al., 2006).
Furthermore, norepinephrine has a stimulatory effect on the
migratory capacity of breast cancer cells (Lillberg et al., 2003)
and colon carcinoma (Prasad et al., 2014), which was inhibited
by b-blockers. In vivo studies of chronic behavioral stress
Figure 5. Autonomic Nerves Are an Active Component of the Tumor
Microenvironment
The tumor microenvironment is heterogeneous and composed of fibroblasts,
blood vessels, nerve fibers, macrophages, and other immune cells that
actively interact with tumor cells to regulate cancer progression. Under stress
situations, nerve fibers recruited within and around the tumor release cate-
cholamines in the tumor stroma. Both tumor cells and stromal cells express
b2-adrenergic receptors (Adrb2), and respond to norepinephrine, which pro-
motes tumor growth. Pericytes, within the tumor microenvironment, express
dopamine receptor type 2 (DR2) and respond to dopamine, which regulates
angiogenesis. Moreover, tumor cells invade autonomic nerves (perineural
invasion) in several cancer types, causing pain, and may facilitate systemic
spreading.
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Perspectiveshow that tumor growth was promoted in a xenograft model of
peritoneal ovarian cancer via direct signaling of b2-adrenergic
receptor expressed by the tumor cells (Thaker et al., 2006).
In this case, the activation of adrenergic receptors led to an
increased secretion of vascular endothelial growth factor
(VEGF) that facilitated angiogenesis and enhanced tumor pro-
gression. At the same time, adrenergic signals protect tumor
cells from programmed cell death in both prostate and ovarian
cancers (Hassan et al., 2013; Sood et al., 2010). In support of a
cell-autonomous adrenergic regulation, catecholamine signaling
mediated by the b2-adrenergic receptor triggers DNA damage
and suppression of p53 levels in a variety of human and murine
cells (Hara et al., 2011). Recent studies also show that cholin-
ergic signals from the vagus nerve regulate gastric tumorigen-
esis by stimulating Wnt signaling into a subset of tumor stem
cells (Zhao et al., 2014). This effect is mediated by themuscarinic
receptor 3 (Chrm3) expressed in Lgr5+ stem cells, and it is abro-
gated by unilateral vagotomy or local botox injection.
As described for hematopoietic malignancies, solid tumor
progression and metastasis do not solely depend on cell-auton-
omous signals, but rely on cues from a remodeled microenviron-
ment. Adrenergic signaling to stromal populations was recently
shown to be essential for tumor initiation in transgenic and
orthotopic xenograft models of prostate cancer, where cancer
cell growth was inhibited in recipient mice deficient for b2- andb3-adrenergic receptors (Magnon et al., 2013). However, the
underlying mechanisms as to how stromal adrenergic signaling
supports tumor growth have not yet been resolved. Potential
candidates in the tumor stroma are macrophages, immune cells,
smooth muscle cells or endothelial cells. All express adrenergic
receptors and are functionally regulated by the ANS (Galasso
et al., 2013; Luja´n et al., 1998; Sanders et al., 1997; Sloan
et al., 2010) (Figure 5). In vitro studies suggest that macrophages
may contribute to adrenergic signaling in the tumor microenvi-
ronment. Human and murine-derived macrophages express
VEGF andmatrix metallopeptidase 9 (Mmp-9) upon norepineph-
rine stimulation (Lutgendorf et al., 2008; Sloan et al., 2010). Up-
regulation of these molecules induces the formation of de novo
blood vessels and promotes tumor cell invasive phenotypes by
remodeling of the extracellular matrix (Sood et al., 2006). Other
subsets of immune cells are known to express adrenergic recep-
tors and respond to stress-mediated signals. B-lymphocytes,
CD4+ naive cells and Th1 cells preferentially express the b2-
adrenergic receptor (Calle and Kaaks, 2004). However, the effect
of catecholamines on these cell populations remains controver-
sial due to result discrepancies reported for different experi-
mental models (Elenkov et al., 2000). In the context of cancer,
only two studies have addressed chronic stress-mediated sig-
nals on immune cells. In rats harboring breast cancer xenografts,
chronic stress promoted tumor proliferation in parallel to the
decrease of leukocytes and T-suppressor cells (Renehan et al.,
2008). Moreover, in a syngeneic model of lymphoma, chronic re-
straint stress reduced the survival of mice andwas accompanied
with a decrease in CD4+ T-lymphocyte numbers and a reduced
production of tumor necrosis factor alpha (TNF-a) and interferon
gamma (Maestroni, 2000). Further work identifying the stromal
SNS target cell is required to fully understand the contribution
of the microenvironment in stress-promoted cancer progres-
sion. Similar to macrophages and immune cells, the tumor
vasculature can also be affected by sympathetic signals. Dopa-
mine has been shown to participate in tumor progression
by affecting the tumor vasculature (Basu et al., 2001; Elenkov
et al., 2000). Dopamine levels are reduced in ovarian carcinoma
from stressed mice, and the exogenous administration of dopa-
mine counteracts the tumor-promoting effects of sympathetic
catecholamines by inhibiting angiogenesis and apoptosis of
tumor cells (Moreno-Smith et al., 2011). Moreover, in a synge-
neic melanoma model, ablation of dopaminergic nerve fibers
or deficiency of the D2 dopamine receptor was associated
with increased angiogenesis and tumor growth (Basu et al.,
2004). These results have important implications in therapy, pri-
marily because the administration of dopamine both stabilized
and normalized tumor vasculature, increasing the delivery and
efficiency of chemotherapy (Chakroborty et al., 2011).
Another element of communication between neurons and
the surrounding tumor environment is the presence of neuro-
peptides, a very heterogeneous group of molecules released
by nerve terminals in both the CNS and the periphery. Different
neuropeptides have been shown to regulate several tumori-
genic functions. For example, neuropeptide Y increases
angiogenesis in xenograft models of neural-crest derived tu-
mors (Kitlinska et al., 2005) and bombesin, neurotensin, and
endothelin-1 are regulating survival and migratory functions ofNeuron 86, April 22, 2015 ª2015 Elsevier Inc. 367
Figure 6. Metastases at Different Sites Are
Regulated by Autonomic Nerve Signals
Both branches of the ANS can promote metastatic
spread of solid tumors. (Left) Lung metastases
are increased in mice harboring breast tumor
xenografts when subjected to chronic stress.
Stress-mediated signals stimulate the recruitment
of CD11b+ F4/80+ macrophages in breast tumor
orthotopic xenografts. These macrophages ex-
press b2-adrenergic receptors and enhance the
lung metastatic capacity of tumor cells without
affecting primary tumor growth. (Right) Muscarinic
receptor 1 (Chrm1) expressed in the tumor
stroma promotes prostate tumor cell invasion and
metastasis to lymph nodes and distant organs.
However, it is not yet known which cell of the
stroma is targeted by parasympathetic signals.
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Perspectiveandrogen-independent prostate tumors (Lee et al., 2001; Sumi-
tomo et al., 2000, Zheng et al., 2006).
The action of the ANS is not restricted to the primary tumor and
may also affect the ability of tumor cells tometastasize (Figure 6).
Different stress regimens including swim-stress, surgical stress,
social confrontation, and hypothermia promote lung metastasis
in breast cancer rat models (Vida et al., 2011; Borovikova et al.,
2000; Goldstein et al., 2007). These effects were mediated
by adrenergic signals because b-adrenergic agonist injections
promoted mammary tumor metastasis. Importantly, the stress
effects on metastasis were prevented by combination pre-treat-
ment with the b-adrenergic antagonist nadolol and indometh-
acin, a nonsteroidal anti-inflammatory drug (Saeed et al., 2005).
In an orthotopic breast cancer model, adrenergic stimulation
induced the infiltration of CD11b+ F4/80+ macrophages, which
in turn promoted metastatic seeding without differences in pri-
mary tumor growth (Sloan et al., 2010). Moreover, inhibition of
the macrophage colony-stimulating factor receptor reverted the
stress-induced metastasis to distant organs.
Parasympathetic signals also mediate specific metastatic
activity. In prostate cancer, carbachol stimulation mediated
by muscarinic receptor type-1 (Chrm1) promoted visceral lymph
node metastasis in orthotopic xenograft models. Moreover,
in transgenic mice overexpressing the oncogene c-Myc in the
prostate, Chrm1 expression in the tumor microenvironment
was dispensable for primary tumor growth but critical for distant
metastases (Magnon et al., 2013). Thus, accumulating evidence
suggests an active role of the ANS in progression and dissemina-
tion of solid tumors, both by acting directly on tumor cells and by
signaling through niche components.
Outlook
From the description by Walter Cannon of the fight-or-flight
response (Cannon, 1929) to the well-described functions in368 Neuron 86, April 22, 2015 ª2015 Elsevier Inc.maintaining steady-state hemodynamics
or metabolism, the role of the ANS in
regulating the stress response and basal
functions has been appreciated for
many years. However, only recently has
the influence of neuronal signals on
stem cell behavior, inflammation, or cellmigration emerged as an important physiological regulating
pathway that may have clinical implications. For example,
knowledge of the circadian release of stem cells may have con-
sequences for the optimal time to harvest HSCs for transplanta-
tion. That tumors induce the growth of new axons contributing
to the cancer opens a new field of study in the cooperation of
nerves and tumor cells and can potentially serve as novel targets
for therapeutic intervention. In this regard, nerve density assess-
ment merits exploration as a possible predictive marker of can-
cer aggressiveness. Much of research in cancer biology has
focused on the genetic basis of cancer, which is extremely
complex and heterogeneous even within the same individual.
Therapies directed at common alterations of the niche may
thus provide a novel approach to harness cancer progression.
Recent clinical studies have already demonstrated that the
intake of b-blockers benefited patients with prostate or breast
cancer (Barron et al., 2011; Grytli et al., 2013; Melhem-Bertrandt
et al., 2011; Perron et al., 2004; Powe et al., 2010), but not colo-
rectal cancer and melanoma (Hicks et al., 2013; McCourt et al.,
2014), indicating that therapies may need to be individualized
for the different cancer types. Treatments with adrenergic
b-receptor inhibitors could also be complemented by agents
blocking parasympathetic receptors to prevent metastasis
development or as a preventive strategy in patients with cancer
predisposition. Because sympathetic nerves promote hemato-
poietic recovery (Lucas et al., 2013), niche-targeted therapies
may also be beneficial in promoting hematopoietic recovery after
neurotoxic chemotherapeutic treatments. Devices and new
methods to stimulate or inhibit nerve function may one day join
the therapeutic options available to treat chronic intractable dis-
eases (Famm et al., 2013). Beneficial effects have already been
observed in pilot clinical trials testing vagus nerve stimulation
for pharmacoresistant epilepsy or rheumatoid arthritis. With
improved delivery of opsins to selected nerve fibers, one could
Neuron
Perspectiveenvision further progress using optogenetics or other emerging
technologies to manipulate selectively local neural input for ther-
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